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Expression of DNA mismatch repair proteins 
and MSH2 polymorphisms in nonmelanoma 
skin cancers of organ transplant recipients
Perrett et al. investigated whether loss of DNA mismatch 
repair (MMR) protein expression and microsatellite insta-
bility are overrepresented in squamous cell carcinomas 
(SCCs) from organ transplant recipients (OTRs) on aza-
thioprine compared with SCCs from immunocompetent 
patients. Results showed no loss of MMR protein expres-
sion in SCCs from OTRs on azathioprine and no associa-
tion between the -6 exon 13 T>C MSH2 polymorphism 
(associated with impaired MMR, drug resistance and cer-
tain cancers) and skin cancer in OTRs on azathioprine. Br 
J Dermatol 2010; 162: 732–42.
Antinuclear antibodies associated  
with loss of response to antitumour necrosis 
factor-a therapy in psoriasis:  
a retrospective, observational study
The aim of this study was to investigate whether the devel-
opment of ANA and anti-dsDNA antibodies while on anti-
tumour necrosis factor (TNF) therapy was associated with 
treatment failure in patients with severe psoriasis. ANA 
developed in 17% of patients on their first treatment, 54% 
of patients who had failed one treatment, 78% of patients 
who had failed two treatments and 83% of patients who 
had failed all three treatments. Anti-dsDNA antibodies 
developed in 2%, 27%, 33% and 83% of patients from the 
same respective groups. The study suggests that the devel-
opment of ANA and anti-dsDNA antibodies may act as 
a marker of forthcoming anti-TNF treatment failure. Br J 
Dermatol 2010; 162: 780–5.
Short-term isotretinoin treatment  
decreases insulin-like growth factor-1 and 
insulin-like growth factor binding protein-3 
levels. Does isotretinoin affect growth 
hormone physiology?
Isotretinoin side-effects such as arthralgia and depres-
sion are similar to those seen in growth hormone (GH) 
deficiency. There are very few studies investigating the 
effect of isotretinoin on GH physiology. Serum insulin-like 
growth factor-1 (IGF-1) and insulin-like growth factor bind-
ing protein-3 (IGFBP3) are GH-dependent markers and are 
useful in screening for GH deficiency. The authors found 
that IGF-1 and IGFBP3 levels decreased significantly after 
treatment (P < 0.01), while an observed decrease in mean 
GH was not significant. Isotretinoin may have a negative 
influence on the GH⁄IGF-1 axis but further studies are 
required to clarify this subject. Br J Dermatol 2010; 162: 
798–802.
T-cell receptor γ gene rearrangement in 
cutaneous T-cell lymphoma:  
comparative study of polymerase chain 
reaction with denaturing gradient gel 
electrophoresis and GeneScan analysis
This study investigated the diagnostic value of T-cell recep-
tor γ gene rearrangement (TCRγ-GR) analysis in cutaneous 
T-cell lymphoma (CTCL) and benign lymphoproliferative 
or inflammatory disorders (BID). Polymerase chain reac-
tion (PCR) with denaturing gradient gel electrophoresis 
(DGGE) analysis and with the BIOMED-2 standardized 
protocol PCR with GeneScan analysis (BIOMED-2-GS) 
had similar diagnostic value for distinguishing CTCL from 
BID, with a sensitivity of 74% and 77%, respectively, and 
a specificity of 86%. Results support the systematic use 
of TCRγ-GR analyses in the diagnosis of CTCL. In view of 
its technical advantages, BIOMED-2-GS may become the 
preferred method for detecting T-cell clonality in CTCL. 
Br J Dermatol 2010; 162: 822–9.
Histological regression in primary melanoma: 
not a predictor of sentinel lymph node 
metastasis in a cohort of 397 patients
This study analysed patients with melanoma who had also 
had a sentinel lymph node (SLN) biopsy. The frequency of 
SLN metastasis was 16% in melanomas with regression 
and 29% without regression (P = 0.012). The adjusted odds 
ratio for regressive melanoma was 0.9 (95% confidence 
interval 0.4–1.9; P = 0.777). It is concluded that the pres-
ence of histological regression within melanoma is not 
associated with an increased risk of SLN metastasis and 
should not be a reason to perform SLN biopsy in patients 
with melanoma. Br J Dermatol 2010; 162: 830–4.
